FDA Calendar: 2H09 Binary Event Trades [View article]
BIEL stated in 6/19/09 PR they have about 720 million shares of stock outstanding, but stock price has still increased by over 700% in past month: www.google.com/finance...
Stock Valuation -- There are currently approximately 720 million outstanding shares, which represent a total market capitalization of approximately $7.2 million.
> I would advise extreme caution on BIEL. In the first quarter of 2009 > alone (January-March) the company nearly doubled its shares outstanding > from 266.9 million to 492.2 million with sales at 0.005 per share > and I would not be shocked if significant additional shares were > issued since then.
New Index of Highly Defensive Market Cap Leaders [View article]
All of the ETF Innovators indexes are featured at my new site and will be tracked at the site in the future, but not initially -- none of the indexes have tickers or associated ETFs/funds yet: www.biomedreports.com/...
New Index of Highly Defensive Market Cap Leaders [View article]
Started last year on 2/1/08 Quarterly Rebalancing Exchanges within one week of mergers Will be tracked on daily closing basis at my new website once the web programmer adds this feature, for now the component stocks are listed: www.biomedreports.com/...
On Feb 26 06:05 PM Anonymous 2 wrote:
> Interesting - but many questions - a few for starters: > on what day/date did this index start? > how often would such a portfolio be reallocated to maintain the equal > weightings? > "who" (at ETF Innovators ?) and how often would exchanges to take > place going forward to allow for mergers?
73 Decision Dates on Updated FDA Calendar [View article]
But since those examples are history --> Look for major upcoming decisions for small/mid-caps CYPB, PTIE, KG, ALO to name a few that will have major stock price impact
On Nov 24 05:23 AM mikehav wrote:
> How about 50% gain or LGND, 103% gain for AMAG, 80% decline for TARG > witihin the last few weeks based on either approval decisions or > panel recommendations
73 Decision Dates on Updated FDA Calendar [View article]
How about 50% gain or LGND, 103% gain for AMAG, 80% decline for TARG witihin the last few weeks based on either approval decisions or panel recommendations
On Nov 23 09:59 AM BlueOkie wrote:
> Nice to know information but not sure how it relates to investment > decisions. Unless a new drug will cause a big move in stock price, > it has only small value.
FDA Calendar: 2H09 Binary Event Trades [View article]
www.google.com/finance...
Stock Valuation -- There are currently approximately 720 million outstanding shares, which represent a total market capitalization of approximately $7.2 million.
finance.yahoo.com/news...
On Jul 27 10:30 PM Dan Weiss wrote:
> I would advise extreme caution on BIEL. In the first quarter of 2009
> alone (January-March) the company nearly doubled its shares outstanding
> from 266.9 million to 492.2 million with sales at 0.005 per share
> and I would not be shocked if significant additional shares were
> issued since then.
New Index of Highly Defensive Market Cap Leaders [View article]
biomedreports.com/blog...
On Jul 14 09:08 AM rusb wrote:
> What happened to ETF Innovators? I cannot find thier web site.
New Index of Highly Defensive Market Cap Leaders [View article]
www.biomedreports.com/...
New Index of Highly Defensive Market Cap Leaders [View article]
Quarterly Rebalancing
Exchanges within one week of mergers
Will be tracked on daily closing basis at my new website once the web programmer adds this feature, for now the component stocks are listed:
www.biomedreports.com/...
On Feb 26 06:05 PM Anonymous 2 wrote:
> Interesting - but many questions - a few for starters:
> on what day/date did this index start?
> how often would such a portfolio be reallocated to maintain the equal
> weightings?
> "who" (at ETF Innovators ?) and how often would exchanges to take
> place going forward to allow for mergers?
73 Decision Dates on Updated FDA Calendar [View article]
On Nov 24 05:23 AM mikehav wrote:
> How about 50% gain or LGND, 103% gain for AMAG, 80% decline for TARG
> witihin the last few weeks based on either approval decisions or
> panel recommendations
73 Decision Dates on Updated FDA Calendar [View article]
On Nov 23 09:59 AM BlueOkie wrote:
> Nice to know information but not sure how it relates to investment
> decisions. Unless a new drug will cause a big move in stock price,
> it has only small value.